Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities

article has not abstract

Vyšlo v časopise: Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities. PLoS Med 8(7): e32767. doi:10.1371/journal.pmed.1001054
Kategorie: Policy Forum
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001054

Souhrn

article has not abstract

Zdroje

1. WHO 19 July 2010 More than five million people receiving HIV treatment [press release]. Available: http://www.who.int/mediacentre/news/releases/2010/hiv_treament_20100719/en/index.html. Accessed 27 May 2011

2. Strengthening Pharmaceutical Systems (SPS) 2009 Supporting pharmacovigilance in developing countries: the systems perspective. Submitted to the U.S. Agency for International Development by the SPS Program, Management Sciences for Health. http://www.msh.org/projects/sps/SPS-Documents/upload/SPS_PV_Paper.pdf. Arlington (Virginia): Management Sciences for Health. Accessed 27 May 2011

3. OlssonSPalSStergachisACouperM 2010 An analysis of pharmacovigilance activities in 55 low -⁠ and middle income countries. Drug Safety 33 689 703

4. BissonGGrossRMillerVWellerIWalkerA 2003 Monitoring of long-term toxicities of HIV treatments: An international perspective. AIDS 17 17 2407 2417

5. Strengthening Pharmaceutical Systems (SPS) Program 2009 Indicator-based pharmacovigilance assessment tool: manual for conducting assessments in developing countries. Submitted to the U.S. Agency for International Development by the SPS Program Arlington (Virginia) Management Sciences for Health

6. PalSNWallbergMCoulterDEdwardsIRRagoL 2010 Cohort event monitoring: a WHO strategy to complement spontaneous reporting systems. Drug Safety 33 939

7. Antiretroviral Pregnancy Registry Steering Committee. 2010 Antiretroviral pregnancy registry international interim report for 1 January 1989 through 31 January 2010. Available: http://www.APRegistry.com. Accessed 27 May 2011

8. PirmohamedMAtuahKNDodooANWinstanleyP 2007 Pharmacovigilance in developing countries. BMJ 335 462

9. XuerefS 2010 Towards a global strategy on pharmacovigilance. Presented at Global Surveillance of Antiretroviral Drug Safety meeting. June 11, 2010, Washington, DC. Available: http://www.hivforum.org/storage/hivforum/documents/PV2010/pharmacovigilance%20gf%20who%20concept%20note%20may%202010.pdf. Accessed 1 June 2011

10. The Global Fund 2010 Guidelines for proposals –⁠ round 10. Section 4.8, Pharmaceutical and Other Health Products. Available: http://www.theglobalfund.org/documents/rounds/10/R10_Guidelines_Single_en.pdf. Accessed 27 May 2011

11. EdwardsIR 2010 African heat. Drug Safety 33 12 1059 1063

12. World Health Organization (WHO) 2009 A practical handbook on the pharmacovigilance of antiretroviral medicines. Available: http://www.who.int/hiv/pub/pharmacovigilance/handbook/en/index.html. Accessed 27 May 2011

13. Uppsala Monitoring Centre 2010 Monitoring Medicines. Available http://www.monitoringmedicines.org/. Accessed 27 May 2011